Zaheer Amna, Komel Aqsa, Abu Bakr Mohammad Baraa, Singh Achit Kumar, Saji Alen Sam, Kharal Manahil Mansha, Ahsan Areeba, Khan Muhammad Hamza, Akbar Anum
Liaquat National Hospital and Medical College.
Department of Internal Medicine, Nishtar Medical University, Multan.
Ann Med Surg (Lond). 2024 Jun 10;86(8):4591-4600. doi: 10.1097/MS9.0000000000002261. eCollection 2024 Aug.
Menstrual blood, which is often discarded as a waste product, has emerged as a valuable source of health information. The components of menstrual blood, such as endometrial cells, immune cells, proteins, and microbial signatures, provide insights into health. Studies have shown encouraging results for using menstrual blood to diagnose a variety of conditions, including hormonal imbalances, cervical cancer, endometriosis, chlamydia, diabetes, and other endocrine disorders. This review examines the potential of menstrual blood as a non-invasive diagnostic specimen, exploring its composition, promising applications, and recent advances. This review also discusses challenges to utilizing menstrual blood testing, including ethical considerations, the lack of standardized collection protocols, extensive validation studies, and the societal stigma around menstruation. Overcoming these challenges will open new avenues for personalized medicine and revolutionize healthcare for individuals who menstruate.
经血通常作为废品被丢弃,如今却已成为健康信息的宝贵来源。经血的成分,如子宫内膜细胞、免疫细胞、蛋白质和微生物特征,能为健康状况提供线索。研究表明,使用经血诊断多种病症,包括激素失衡、宫颈癌、子宫内膜异位症、衣原体感染、糖尿病和其他内分泌失调,已取得令人鼓舞的成果。本综述探讨了经血作为非侵入性诊断标本的潜力,研究了其成分、有前景的应用及最新进展。本综述还讨论了利用经血检测所面临的挑战,包括伦理考量、缺乏标准化采集方案、广泛的验证研究以及围绕月经的社会污名。克服这些挑战将为个性化医疗开辟新途径,并彻底改变针对经期女性的医疗保健。